COLINZ LABORATORIES LIMITED
A-101, Pratik Ind. Estate, Next to Fortis Hospital, Mulund-Goregaon Link Road, Mumbai - 400 078.

UN-AUDITED FINANCIAL RESULTS FOR QUATERS ENDED 30TH JUNE 2011

  (Rupees in '000')
S. No. Particulars Un -audited Audited
Quarter Ended Quarter Ended Year Ended
30.06.2011 30.06.2010 31.03.2011
1.
Net Sales
2,19,72
1,75,78
6,03,36
2.
Other Income
29
43
2,22
3.
Total Income
2,20,01
1,76,21
6,05,58
4.
Total Expenditure
 
(a) Increase/ Decrease in Stock in Trade
44,26
- 3,79
-23,11
 
(b) Consumption of Materials
69,25
86,09
2,40,79
 
(c) Excise Duty
7,97
5,66
33,13
 
(d) Staff Cos
41,43
36,96
1,50,94
 
(e) Other Expenditure
43,37
39,50
1,54,60
5.
Profit before Interest. Depreciation and Taxation
13,73
11,79
49,23
6.
Interest
4,10
3,45
15,61
7.
Depreciation
6,44
6,43
25,77
8.
Profit Before Tax
3,19
1,91
7,85
9.
Provision for Current Tax
-
-
1,34
10.
Provision for Deferred Tax
-
-
(78)
11.
Fringe Benefit Tax
-
-
-
12.
Net Profit afterTax
3,19
1,91
7,29
13.

Paid up Equity Share Capital [Net of allotment money in arrears]

3,54,35
3,54,35
3,54,35
14.
Reserves Excluding Revaluation Reserves Less Deferred Tax Provision
-
-
65,26
15.
E. P. S.
-
-
0.16
16.
Aggregate of non promoter share -holding.

Aggregate of non promoter share -holding.
No. of shares

-Percentages of shareholding

29,02,900

63.51%

28,99,900

63.44%

29,02,900

63.51%
17.

Promoters and promoter group
Shareholding
a) Pledged/Encumbered

- Number of shares
-
-
-
 

- Percentage of shares (as a % of the total shareholding of promoter and promoter group)

-
-
-
 

- Percentage of shares (as a% of
the total share capital of the company)

-
-
-
 

b) Non-encumbered

- Number of Shares
16,68,100
16,71,100
16,68,100
 

- Percentage of shares (as a% of the total shareholding of promoter and promoter group)

100%
100%
100%
 

- Percentage of shares (as a % of
the total share capital of the company)

36.49%
36.56%
36.49%

 

(Rupees in ‘ 000)
STATEMENT OF ASSETS AND LIABILITES

 

As on 30.06.2011
(Un-Audited)

As on 30.03.2011
(Audited)

CAPITAL & LIABILITIES    

Capital
Reserve and Surplus
Secured Loan
Other Liabilities

Total

3,54,35
2,86,49
72,84
1,54,19

8,67,87

3,54,35
2,83,30
1,30,84
1,53,83

              9,22,32

ASSETS    

 

Investment
Fixed Assets
Net Current Assets

Total

 

31,59
4,34,86
4,01,42

8,67,87

 

31,59
4,41,31
4,49,42

9,22,32

 

NOTES :-

  1. The above results subjected to ‘Limited Review’ by the Auditors of the Company, were taken on record by the Board of Directors of the Company, at their meeting held on   
    30.07.2011

  2. The Un-audited results for the quarter do not reflect the trend for the year.

  3. Income Tax provision, whatever found necessary, will be considered at the end of the year

  4. The company operates in single segment of manufacture of pharmaceutical formulations. Hence Accounting Standard on segment reporting is not applicable

  5. The Company did not have any investors’ complaint pending at the beginning of the quarter. No investors’ complaints were received during the quarter and hence no investors’ complaints remained unsolved at the end of the quarter ended 30-06-2011.

 

  For and on behalf of the Board
  M/S. COLINZ LABORATORIES LIMITED
   
Mumbai Dr. L. S. Mani
30.07.2011 Chairman & Managing Director.

 

(Top)

COLINZ LABORATORIES LTD.
Registered Office:
A/101, Pratik Estate,
Mulund-Goregaon Link Raod
Bhandup(w),
Mumbai-400078.
Tel, No. 022-25668002.
Investors Grievance Email:
colinzlabs@yahoo.com
Person to be contacted:
Mr. Ganesh Chitte
RTA Email:
investor@bigshareonline.com
Person to be contacted:
Mr. Rajesh Mishra
Website:www.findoc-cll.in